Clinical trial
A Phase II Study of Concurrent Nab-Paclitaxel, Carboplatin and Thoracic Radiotherapy in Local Advanced Squamous Cell Lung Cancer
NCT01494415 is registered in ClinicalTrials.gov with First People's Hospital of Hangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Concurrent Nab-Paclitaxel, Carboplatin and Thoracic Radiotherapy in Local Advanced Squamous Cell Lung Cancer
- Lead sponsor
- First People's Hospital of Hangzhou
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2012
- Completion date
- June 30, 2017
- Enrollment
- 21 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.